Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Alzheimer’s Therapeutic Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Memantine Hydrochloride
      • 1.3.3 Donepezil Hydrochloride
      • 1.3.4 Rivastigmine
      • 1.3.5 Galantamine Hydrobromide
    • 1.4 Market Segment by Application
      • 1.4.1 Global Alzheimer’s Therapeutic Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinic
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Alzheimer’s Therapeutic Market Size
      • 2.1.1 Global Alzheimer’s Therapeutic Revenue 2014-2025
      • 2.1.2 Global Alzheimer’s Therapeutic Sales 2014-2025
    • 2.2 Alzheimer’s Therapeutic Growth Rate by Regions
      • 2.2.1 Global Alzheimer’s Therapeutic Sales by Regions 2014-2019
      • 2.2.2 Global Alzheimer’s Therapeutic Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Alzheimer’s Therapeutic Sales by Manufacturers
      • 3.1.1 Alzheimer’s Therapeutic Sales by Manufacturers 2014-2019
      • 3.1.2 Alzheimer’s Therapeutic Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Alzheimer’s Therapeutic Revenue by Manufacturers (2014-2019)
      • 3.2.2 Alzheimer’s Therapeutic Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Alzheimer’s Therapeutic Market Concentration Ratio (CR5 and HHI)
    • 3.3 Alzheimer’s Therapeutic Price by Manufacturers
    • 3.4 Key Manufacturers Alzheimer’s Therapeutic Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Alzheimer’s Therapeutic Market
    • 3.6 Key Manufacturers Alzheimer’s Therapeutic Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Memantine Hydrochloride Sales and Revenue (2014-2019)
      • 4.1.2 Donepezil Hydrochloride Sales and Revenue (2014-2019)
      • 4.1.3 Rivastigmine Sales and Revenue (2014-2019)
      • 4.1.4 Galantamine Hydrobromide Sales and Revenue (2014-2019)
    • 4.2 Global Alzheimer’s Therapeutic Sales Market Share by Type
    • 4.3 Global Alzheimer’s Therapeutic Revenue Market Share by Type
    • 4.4 Alzheimer’s Therapeutic Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Alzheimer’s Therapeutic Sales by Application

    6 United States

    • 6.1 United States Alzheimer’s Therapeutic Breakdown Data by Company
    • 6.2 United States Alzheimer’s Therapeutic Breakdown Data by Type
    • 6.3 United States Alzheimer’s Therapeutic Breakdown Data by Application

    7 European Union

    • 7.1 European Union Alzheimer’s Therapeutic Breakdown Data by Company
    • 7.2 European Union Alzheimer’s Therapeutic Breakdown Data by Type
    • 7.3 European Union Alzheimer’s Therapeutic Breakdown Data by Application

    8 China

    • 8.1 China Alzheimer’s Therapeutic Breakdown Data by Company
    • 8.2 China Alzheimer’s Therapeutic Breakdown Data by Type
    • 8.3 China Alzheimer’s Therapeutic Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Alzheimer’s Therapeutic Breakdown Data by Company
    • 9.2 Rest of World Alzheimer’s Therapeutic Breakdown Data by Type
    • 9.3 Rest of World Alzheimer’s Therapeutic Breakdown Data by Application
    • 9.4 Rest of World Alzheimer’s Therapeutic Breakdown Data by Countries
      • 9.4.1 Rest of World Alzheimer’s Therapeutic Sales by Countries
      • 9.4.2 Rest of World Alzheimer’s Therapeutic Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer Inc
      • 10.1.1 Pfizer Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.1.4 Alzheimer’s Therapeutic Product Introduction
      • 10.1.5 Pfizer Inc Recent Development
    • 10.2 Novartis International AG
      • 10.2.1 Novartis International AG Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.2.4 Alzheimer’s Therapeutic Product Introduction
      • 10.2.5 Novartis International AG Recent Development
    • 10.3 Axovant Sciences Ltd
      • 10.3.1 Axovant Sciences Ltd Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.3.4 Alzheimer’s Therapeutic Product Introduction
      • 10.3.5 Axovant Sciences Ltd Recent Development
    • 10.4 Acadia Pharmaceuticals, Inc
      • 10.4.1 Acadia Pharmaceuticals, Inc Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.4.4 Alzheimer’s Therapeutic Product Introduction
      • 10.4.5 Acadia Pharmaceuticals, Inc Recent Development
    • 10.5 Biotie Therapies
      • 10.5.1 Biotie Therapies Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.5.4 Alzheimer’s Therapeutic Product Introduction
      • 10.5.5 Biotie Therapies Recent Development
    • 10.6 Astra Zeneca plc
      • 10.6.1 Astra Zeneca plc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.6.4 Alzheimer’s Therapeutic Product Introduction
      • 10.6.5 Astra Zeneca plc Recent Development
    • 10.7 Eli Lilly, Inc
      • 10.7.1 Eli Lilly, Inc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.7.4 Alzheimer’s Therapeutic Product Introduction
      • 10.7.5 Eli Lilly, Inc Recent Development
    • 10.8 F. Hoffman Le Roche
      • 10.8.1 F. Hoffman Le Roche Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.8.4 Alzheimer’s Therapeutic Product Introduction
      • 10.8.5 F. Hoffman Le Roche Recent Development
    • 10.9 Merck & Co
      • 10.9.1 Merck & Co Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.9.4 Alzheimer’s Therapeutic Product Introduction
      • 10.9.5 Merck & Co Recent Development
    • 10.10 H. Lundbeck A/S
      • 10.10.1 H. Lundbeck A/S Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Alzheimer’s Therapeutic
      • 10.10.4 Alzheimer’s Therapeutic Product Introduction
      • 10.10.5 H. Lundbeck A/S Recent Development
    • 10.11 Takeda Pharmaceutical Company Ltd

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Alzheimer’s Therapeutic Sales Channels
      • 11.2.2 Alzheimer’s Therapeutic Distributors
    • 11.3 Alzheimer’s Therapeutic Customers

    12 Market Forecast

    • 12.1 Global Alzheimer’s Therapeutic Sales and Revenue Forecast 2019-2025
    • 12.2 Global Alzheimer’s Therapeutic Sales Forecast by Type
    • 12.3 Global Alzheimer’s Therapeutic Sales Forecast by Application
    • 12.4 Alzheimer’s Therapeutic Forecast by Regions
      • 12.4.1 Global Alzheimer’s Therapeutic Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Alzheimer’s Therapeutic Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Alzheimer’s Therapeutic is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alzheimer’s Therapeutic.

      This report studies the global market size of Alzheimer’s Therapeutic, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Alzheimer’s Therapeutic sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer Inc
      Novartis International AG
      Axovant Sciences Ltd
      Acadia Pharmaceuticals, Inc
      Biotie Therapies
      Astra Zeneca plc
      Eli Lilly, Inc
      F. Hoffman Le Roche
      Merck & Co
      H. Lundbeck A/S
      Takeda Pharmaceutical Company Ltd

      Market Segment by Product Type
      Memantine Hydrochloride
      Donepezil Hydrochloride
      Rivastigmine
      Galantamine Hydrobromide

      Market Segment by Application
      Hospitals
      Clinic
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Alzheimer’s Therapeutic status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Alzheimer’s Therapeutic manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Alzheimer’s Therapeutic are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now